226 related articles for article (PubMed ID: 34238473)
1. Animal models for Prader-Willi syndrome.
Zahova S; Isles AR
Handb Clin Neurol; 2021; 181():391-404. PubMed ID: 34238473
[TBL] [Abstract][Full Text] [Related]
2. Advances in genetic mechanisms of hypothalamic dysfunction in Prader-Willi syndrome.
Wang XY; Sun R; Gao YQ
Yi Chuan; 2022 Oct; 44(10):899-912. PubMed ID: 36384726
[TBL] [Abstract][Full Text] [Related]
3. Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader-Willi syndrome.
Davies JR; Humby T; Dwyer DM; Garfield AS; Furby H; Wilkinson LS; Wells T; Isles AR
Eur J Neurosci; 2015 Aug; 42(4):2105-13. PubMed ID: 26040449
[TBL] [Abstract][Full Text] [Related]
4. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
5. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
Wevrick R
Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
[TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Review of Genetically Engineered Mouse Models for Prader-Willi Syndrome Research.
Kummerfeld DM; Raabe CA; Brosius J; Mo D; Skryabin BV; Rozhdestvensky TS
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807162
[TBL] [Abstract][Full Text] [Related]
7. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
Angulo MA; Butler MG; Cataletto ME
J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
[TBL] [Abstract][Full Text] [Related]
8. Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review.
Pellikaan K; Nguyen NQC; Rosenberg AGW; Coupaye M; Goldstone AP; Høybye C; Markovic T; Grugni G; Crinò A; Caixàs A; Poitou C; Corripio R; Nieuwenhuize RM; van der Lely AJ; de Graaff LCG
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1720-e1730. PubMed ID: 37267430
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the investigation of animal models of Prader-Willi syndrome.
Resnick JL; Nicholls RD; Wevrick R;
Mamm Genome; 2013 Jun; 24(5-6):165-78. PubMed ID: 23609791
[TBL] [Abstract][Full Text] [Related]
10. Prader-Willi Syndrome: Molecular Mechanism and Epigenetic Therapy.
Mian-Ling Z; Yun-Qi C; Chao-Chun Z
Curr Gene Ther; 2020; 20(1):36-43. PubMed ID: 32329685
[TBL] [Abstract][Full Text] [Related]
11. Prader-Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review.
Butler MG
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901699
[TBL] [Abstract][Full Text] [Related]
12. Three siblings with Prader-Willi syndrome caused by imprinting center microdeletions and review.
Hartin SN; Hossain WA; Weisensel N; Butler MG
Am J Med Genet A; 2018 Apr; 176(4):886-895. PubMed ID: 29437285
[TBL] [Abstract][Full Text] [Related]
13. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome.
Dykens EM; Roof E; Hunt-Hawkins H
Orphanet J Rare Dis; 2024 Feb; 19(1):83. PubMed ID: 38395848
[TBL] [Abstract][Full Text] [Related]
14. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
Bittel DC; Kibiryeva N; Butler MG
Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation of the dopamine transporter (DAT) gene promoter is associated with hyperphagia-related behavior in Prader-Willi syndrome: A case-control study.
Wieting J; Jahn K; Eberlein CK; Bleich S; Frieling H; Deest M
Behav Brain Res; 2023 Jul; 450():114494. PubMed ID: 37182741
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical leanness in the imprinting-centre deletion mouse model for Prader-Willi syndrome.
Golding DM; Rees DJ; Davies JR; Relkovic D; Furby HV; Guschina IA; Hopkins AL; Davies JS; Resnick JL; Isles AR; Wells T
J Endocrinol; 2017 Jan; 232(1):123-135. PubMed ID: 27799465
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
[TBL] [Abstract][Full Text] [Related]
18. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment.
Goldstone AP
Trends Endocrinol Metab; 2004; 15(1):12-20. PubMed ID: 14693421
[TBL] [Abstract][Full Text] [Related]
19. Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review.
Napolitano L; Barone B; Morra S; Celentano G; La Rocca R; Capece M; Morgera V; Turco C; Caputo VF; Spena G; Romano L; De Luca L; Califano G; Collà Ruvolo C; Mangiapia F; Mirone V; Longo N; Creta M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671467
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mouse models reveals a molecular distinction between psychotic illness in PWS and schizophrenia.
Zahova SK; Humby T; Davies JR; Morgan JE; Isles AR
Transl Psychiatry; 2021 Aug; 11(1):433. PubMed ID: 34417445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
